Home / News / World News / Article /
Study finds Omicron evades vaccines, antibody therapies
Updated On: 25 December, 2021 07:24 AM IST | Washington | Agencies
Says new variant is resistant to current antibody therapies, highlights need for new vaccines and treatments that anticipate how SARS-CoV-2 virus may evolve
Listen to this article :
Health workers administer Covid-19 PCR tests at an outdoor testing site aside the Long Island Sound on December 23 in Stamford, Connecticut as people scramble to get tested ahead of Christmas. Pic/AFP
Omicron can evade the immune protection conferred by Covid-19 vaccines and natural infection, according to a peer-reviewed study which also suggests that the new variant of coronavirus is completely resistant to antibody therapies in use today. The study, published in the journal Nature on Thursday, also highlights the need for new vaccines and treatments that anticipate how the SARS-CoV-2 virus may soon evolve.
The researchers from Columbia University in the US and the University of Hong Kong noted that a striking feature of Omicron is the alarming number of changes in the variant’s spike protein that could pose a threat to the effectiveness of current vaccines and therapeutic antibodies.
Trending Stories
Latest Photos
Latest Videos
Latest Web Stories
ADVERTISEMENT
Mid-Day Fast
ADVERTISEMENT
ADVERTISEMENT